Prognostic implication of CDC25A and cyclin E expression on primary breast cancer patients

Cell Biology International

Volumn 33, Issue 10, 2009, Pages 1050-1056

  Mehdipour, Parvin ^a   Pirouzpanah, Saeed ^a   Sarafnejad, Abdolfattah ^b   Atri, Morteza ^b   Tahereh Shahrestani, S ^b   Haidari, Mojgan ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; CDC25A; Cyclin E; Ki 67 labeling index; Survival

Indexed keywords

CELL DIVISION CYCLE 25A PHOSPHATASE; CYCLIN E; KI 67 ANTIGEN; PHOSPHATASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GENE AMPLIFICATION; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; UPREGULATION;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA; CDC25 PHOSPHATASES; CYCLIN E; FEMALE; HUMANS; KI-67 ANTIGEN; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 69549086358     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2009.06.016     Document Type: Article

References (17)

1. Berglund P., and Landberg G. Cyclin E overexpression reduces infiltrative growth in breast cancer. Cell Cycle 5 6 (2006) 606-609
2. Bonin S., Brunetti D., Benedetti E., Gorji N., and Stanta G. Expression of cyclin-dependent kinases and CDC25a phosphatase is related with recurrences and survival in women with peri- and post-menopausal breast cancer. Virchows Arch 448 5 (2006) 539-544
3. Bortner D.M., and Rosenberg M.P. Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Mol Cell Biol 17 (1997) 453-459
4. Cangi M.G., Cukor B., Soung P., Signoretti S., Moreira G., Ranashinge M., et al. Role of the Cdc25A phosphatase in human breast cancer. J Clin Invest 106 6 (2000) 753-761
5. Ekholm-Reed S., Mendez J., Tedesco D., Zetterberg A., Stillman B., and Reed S.I. Deregulation of cyclin E in human cells interferes with prereplication complex assembly. J Cell Biol 165 (2004) 789-800
6. Galaktionov K., Lee A.K., Eckstein J., Draetta G., Meckler J., Massimo L., et al. Cdc25 phosphatases as potential human oncogenes. Science (Washington DC) 269 (1995) 1575-1577
7. Han S., Park K., Bae B., Kim K.H., Kim H.J., Kim Y.D., et al. Prognostic implication of cyclin E expression and its relationship with cyclin D1 and p27kip1 expression on tissue microarrays of node negative breast cancer. J Surg Oncol 83 (2003) 241-247
8. Husdal A., Bukholm G., and Bukholm I.R. The prognostic value and overexpression of cyclin A is correlated with gene amplification of both cyclin A and cyclin E in breast cancer patient. Cell Oncol 28 3 (2006) 107-116
9. Kawamura K., Izumi H., Ma Z., Ikeda R., Moriyama M., Tanaka T., et al. Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression. Cancer Res 64 (2004) 4800-4809
10. Konigsberg R., Rogelsperger O., Jager W., Thalhammer T., Klimpfinger M., De Santis M., et al. Cell cycle dysregulation influences survival in high risk breast cancer patients. Cancer Invest 26 7 (2008) 734-740
11. Lindahl T., Landberg G., Ahlgren J., Nordgren H., Norberg T., Klaar S., et al. Overexpression of cyclin E protein is associated with specific mutation types in the p53gene and poor survival in human breast cancer. Carcinogenesis 25 (2004) 375-380
12. Nielsen N.H., Arnerlov C., Emdin S.O., and Landberg G. Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status. Br J Cancer 74 (1996) 874-880
13. Ohtsubo M., Theodoras A.M., Schumacher J., Roberts J.M., and Pagano M. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol 15 (1995) 2612-2624
14. Qu Z., Weiss J.N., and MacLellan W.R. Regulation of the mammalian cell cycle: a model of the G1-to-S transition. Am J Physiol Cell Physiol 284 (2003) 349-364
15. Sandhu C., Donovan J.R., Bhattacharya N., Stampfer M., Worland P., and Slingerland J. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells. Oncogene 19 (2000) 5314-5323
16. Tandis S.H., Murray T., Bolden S., and Wingo P.A. Cancer statistics. CA Cancer J Clin 48 (1998) 6-29
17. Wu W., Fan Y., Kemp B.L., Walsh G., and Mao L. Overexpression of cdc25A and cdc25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of c-myc. Cancer Res 58 (1998) 4082-4085